©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Jul 6, 2015; 4(3): 388-395
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.388
Published online Jul 6, 2015. doi: 10.5527/wjn.v4.i3.388
Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients
Minoru Ando, Division of Nephrology, Department of Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan
Naoki Yanagisawa, Division of Infectious Diseases, Department of Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan
Author contributions: Ando M and Yanagisawa N contributed equally to this work, and generated the figures and tables; Ando M chiefly wrote the manuscript.
Conflict-of-interest statment: None declared.
Correspondence to: Minoru Ando, MD, PhD, Division of Nephrology, Department of Medicine, Tokyo Metropolitan Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-Ku, Tokyo 113-8677, Japan. hdcn@cick.jp
Telephone: +81-3-38232101 Fax: +81-3-38241552
Received: June 24, 2014
Peer-review started: June 25, 2014
First decision: September 16, 2014
Revised: October 10, 2014
Accepted: April 8, 2015
Article in press: April 9, 2015
Published online: July 6, 2015
Processing time: 377 Days and 2.5 Hours
Peer-review started: June 25, 2014
First decision: September 16, 2014
Revised: October 10, 2014
Accepted: April 8, 2015
Article in press: April 9, 2015
Published online: July 6, 2015
Processing time: 377 Days and 2.5 Hours
Core Tip
Core tip: Kidneys are affected by the human immunode-